Rv2656c: A Potential Candidate Antigen Associated with Latent Tuberculosis Infection
Vaccines · 15.05.2026 · 14 (5) · 442
DOI: 10.3390/vaccines14050442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 15.05.2026. Verfasst von Yunjie Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Animal Disease Control and Prevention and Lanzhou Center for Tuberculosis Research, Institute of Pathogen Biology, School of …. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Science and Technology Project of Gansu Province, the National Key Research and Development Program of China, Gansu Science and Technology Project.
Abstract (Originalsprache)
Background/Objectives: Several subunit vaccines for tuberculosis (TB), such as MVA85A and H4:IC31, have not demonstrated ideal protective efficacy in clinical trials, which may be attributed to their limited antigenic profile and lack of effective latency-associated antigens. In this study, we combined bioinformatics with experimental validation to screen for latency-associated antigens that have immune-protective effects.
Methods
Highly expressed antigens were identified from models related to latent infections, such as hypoxia and nutritional starvation. Their physicochemical properties and immunogenicity were predicted using online tools such as Expasy-ProParam, IEBD, and VaxiJen. The immunogenicity of these antigens was then evaluated in multiple mycobacterium infection models. Finally, a systematic evaluation of the immune response and protective effects induced by the candidate antigens was performed in a mouse model using intracellular cytokine detection, mycobacterium growth inhibition assays (MGIAs), antibody-dependent cellular phagocytosis (ADCP), and a latent tuberculosis infection (LTBI) mouse model.
Results
The antigen Rv2656c is highly expressed in the nutritional starvation model and demonstrates strong immunogenicity in both infected humans and cattle. Moreover, Rv2656c exerted a significant inhibitory effect against Mycobacterium tuberculosis (M. tuberculosis) and Mycobacterium avium (M. avium) infections in MGIA. The humoral immune response elicited by Rv2656c enhanced the phagocytosis and killing of Mycobacteria by macrophages in vitro. Furthermore, in a mouse model of LTBI established using the attenuated M. tuberculosis H37Ra strain, treatment with Rv2656c significantly decreased the bacterial load in the lungs of the mice.
Conclusions
Latency-associated Rv2656c may serve as an immune-protective antigen, offering potential for the development of novel multi-stage antigen subunit vaccine against TB.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Animal Disease Control and Prevention and Lanzhou Center for Tuberculosis Research, Institute of Pathogen Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
- School of Life Science, Lanzhou University, Lanzhou 730000, China.
- State Key Laboratory of Animal Disease Control and Prevention, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730000, China.
- State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China.
- College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730000, China.
ORCID-Profile: Yunjie Du, Bingdong Zhu
Förderung
- Major Science and Technology Project of Gansu Province
- the National Key Research and Development Program of China
- Gansu Science and Technology Project
- Science and Technology Major Project of Gansu Province
- National Key Research and Development Program of China
Zitieren
APA
Du, Y., He, P., Dang, W., Zhou, T., Song, Y., Li, X., Zhao, Y., Li, F., Guo, A., & Zhu, B. (2026). Rv2656c: A Potential Candidate Antigen Associated with Latent Tuberculosis Infection. Vaccines, 14(5), 442. https://doi.org/10.3390/vaccines14050442
Vancouver
Du Y, He P, Dang W, Zhou T, Song Y, Li X, et al. Rv2656c: A Potential Candidate Antigen Associated with Latent Tuberculosis Infection. Vaccines. 2026;14(5):442. doi:10.3390/vaccines14050442
BibTeX
@article{Du2026,
author = {Du, Yunjie and He, Pu and Dang, Wenrui and Zhou, Ting and Song, Yinjuan and Li, Xiaoping and Zhao, Yuhao and Li, Fei and Guo, Aizhen and Zhu, Bingdong},
title = {Rv2656c: A Potential Candidate Antigen Associated with Latent Tuberculosis Infection},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {5},
pages = {442},
doi = {10.3390/vaccines14050442}
}
EUVIMED